News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
The test is the first offered for the Sgx Clarity system, a fully automated in vitro diagnostic platform leveraging single-molecule counting technology.
The panel is the Danish firm's first commercial product. While the CE mark is for IVD use, the company plans to get CE marking for self-testing later this year.
The test, which went off the market when its original seller closed shop, uses an ultracentrifuge and spectrophotometer to measure cholesterol and triglycerides.